Skip to main content

WPI 3630 Pill - yellow round

Pill with imprint WPI 3630 is Yellow, Round and has been identified as Hydromorphone Hydrochloride Extended-Release 16 mg. It is supplied by Watson Laboratories, Inc.

Hydromorphone is used in the treatment of Chronic Pain; Pain; Cough; Anesthetic Adjunct and belongs to the drug class Opioids (narcotic analgesics). Risk cannot be ruled out during pregnancy. Hydromorphone 16 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3630

Hydromorphone hydrochloride extended-release 16 mg WPI 3630
Hydromorphone hydrochloride extended-release 16 mg WPI 3630

Hydromorphone Hydrochloride Extended-Release

Imprint
WPI 3630
Strength
16 mg
Color
Yellow
Shape
Round
Availability
Prescription only
Drug Class
Opioids (narcotic analgesics)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
00591-3630 (Discontinued)
Inactive Ingredients
cellulose acetate, copovidone, hypromelloses, ferrosoferric oxide, ferric oxide red, ferric oxide yellow, lactose monohydrate, magnesium stearate, polyethylene glycol, propylene glycol, sodium chloride, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer